8-K: Alaunos Therapeutics Changes Independent Auditor from RSM to Cherry Bekaert

Alaunos Therapeutics has dismissed RSM US LLP as its independent auditor and appointed Cherry Bekaert LLP, effective June 19, 2024.

Summary

• Alaunos Therapeutics dismissed RSM US LLP as their independent registered public accounting firm on June 19, 2024.
• The decision was approved by the company's Audit Committee and was not due to any disagreements with RSM.
• RSM's reports on the company's financial statements for 2022 and 2023 did not contain any adverse opinions or disclaimers, but included an explanatory paragraph about the company's ability to continue as a going concern.
• There were no disagreements or reportable events between Alaunos and RSM regarding accounting principles, financial disclosures, or auditing scope.
• Alaunos has engaged Cherry Bekaert LLP as its new independent registered public accounting firm, also effective June 19, 2024.
• The company did not consult with Cherry Bekaert prior to the appointment regarding accounting principles or audit opinions.

Sentiment

Score: 6

Explanation: The change in auditors is not inherently negative, but the going concern warning from the previous auditor is a concern. The lack of disagreements is a positive sign.

Positives

• The change in auditors was not due to any disagreements on accounting or auditing matters, suggesting a smooth transition.
• RSM has been authorized to respond fully to inquiries from the new auditor, ensuring continuity and transparency.

Negatives

• RSM's reports for 2022 and 2023 included an explanatory paragraph indicating substantial doubt about the company's ability to continue as a going concern.

Risks

• The going concern warning in RSM's reports indicates potential financial instability for Alaunos.
• Changing auditors can sometimes signal underlying issues, although this is not the case here according to the document.

Industry Context

Changes in auditors are not uncommon, but they are often scrutinized by investors for potential underlying issues. In this case, the company explicitly states that the change was not due to any disagreements.

Comparison to Industry Standards

• The change of auditors is a common event in the corporate world, and the process described by Alaunos is standard practice.
• Companies like Amgen, Gilead, and Regeneron also use large accounting firms for their audits, and changes are sometimes made for various reasons.
• The going concern warning is a serious issue that is not uncommon for biotech companies in the development stage, but it is a red flag for investors.

Stakeholder Impact

• Shareholders may be concerned about the going concern warning, but the smooth transition of auditors should be reassuring.
• Employees may be indirectly affected by the financial stability concerns.

Key Dates

Keywords

auditor, accounting, RSM, Cherry Bekaert, financial statements, going concern, audit committee